Cystic Fibrosis Foundation - Click here for homepage
Stay Informed  |  Volunteer  |  Clinical Trials

In This Section

Quick Links

Find a Chapter

Get Assistance

Get Assistance - Cox Boys
We are here to help people with CF get the insurance coverage they need. Hear how the Foundation helped the Cox family.

Join us on Facebook!  Facebook 
Follow us on Twitter!  Twitter 
  Google+ 
Subscribe to our channel on YouTube!  YouTube  


Print  
Denufosol Recognized as Promising New Therapy

December 28, 2006

Denufosol, a potential new therapeutic for CF, has just been listed as one of the top five most promising drugs entering phase 3 clinical trials according to industry analyst, Thomson Pharma. Created by Inspire Pharmaceuticals, denufosol is designed to improve chloride transport in CF airways and enhance mucosal hydration and clearance. CF patients who took denufosol in a Phase 2 clinical trial had significantly better lung function than patients taking placebo at the end of that trial.

Denufosol has received Fast Track and Orphan Drug status in the United States. Recruitment for a Phase 3 clinical trial is ongoing. For more information, go to www.inspirepharm.com or call (919) 287-1286.

The Cystic Fibrosis Foundation is an accredited charity of the Better Business Bureau.